Clustering of ABCB1 and CYP2C19 Genetic Variants Predicts Risk of Major Bleeding and Thrombotic Events in Elderly Patients with Acute Coronary Syndrome Receiving Dual Antiplatelet Therapy with Aspirin and Clopidogrel-Reference-Cited by-同舟云学术

Clustering of ABCB1 and CYP2C19 Genetic Variants Predicts Risk of Major Bleeding and Thrombotic Events in Elderly Patients with Acute Coronary Syndrome Receiving Dual Antiplatelet Therapy with Aspirin and Clopidogrel

Published:2018-06-23 Issue:7 Volume:35 Page:649-656
ISSN:1170-229X
Container-title:Drugs & Aging
language:en
Short-container-title:Drugs Aging

Author:

Galeazzi Roberta,Olivieri Fabiola,Spazzafumo Liana,Rose Giuseppina,Montesanto Alberto,Giovagnetti Simona,Cecchini Sara,Malatesta Gelsomina^ORCID,Di Pillo Raffaele,Antonicelli Roberto

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Geriatrics and Gerontology

Link

http://link.springer.com/article/10.1007/s40266-018-0555-1/fulltext.html

Reference43 articles.

1. Roffi M, Patrono C, et al. ESC Guidelines for the management of acute coronary sindrome in patients presenting without persistent ST-segment elevation. Eur Heart J. 2016;37(3):267–315.

2. Thomson RM, Anderson DC. Aspirin and clopidogrel for prevention of ischemic stroke. Curr Neurol Neurosci Rep. 2013;13:327. https://doi.org/10.1007/s11910-012-0327-y .

3. Thomas K, Kessler C. New antiplatelet agents prescribed to patients with ischemic heart disease: implications for treatment of stroke. Curr Treat Options Neurol. 2014;16:289. https://doi.org/10.1007/s11940-014-0289-2 .

4. Chen ZM, Jiang LX, Chen YP, et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005;366:1607–21.

5. Lyseng-Williamson KA, Plosker GL. Clopidogrel: a pharmacoeconomic review of its use in patients with non-ST elevation acute coronary syndromes. Pharmacoeconomics. 2006;24:709–26.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miR-6076 rs1463411 polymorphisms are associated with bleeding during clopidogrel treatment in patients with acute coronary syndrome;European Journal of Medical Research;2023-02-24

2. Research Progress on Related Genes of Clopidogrel Resistance;Advances in Clinical Medicine;2023

3. Impact of <i>CYP2C19</i> gene polymorphisms on clinical outcomes in patients with myocardial infarction during 12-month follow-up;Complex Issues of Cardiovascular Diseases;2022-08-08

4. Dosage optimization of clopidogrel via a precision medicine approach: the way forward;Pharmacogenomics;2022-02

5. The Role of Pharmacogenetics in Antithrombotic Therapy Management: New Achievements and Barriers Yet to Overcome;Current Medicinal Chemistry;2021-10-15